The latest myeloma news
Looking at the urine and blood may be best in diagnosing myeloma
When it comes to diagnosing a condition in which the plasma cells that normally make…
Browsing: Myeloma
EHA 23: Results of OPTIMISMM study show triplet combination improved PFS in early lines of r/r MM
Results from the OPTIMISMM study, a phase III, randomised, open-label, international clinical study of the…
Modern blood cancer treatments require new approach for monitoring, reporting side effects
Treatment changes including the advent of targeted and immune therapies have dramatically improved survival for…
Multiple sclerosis drug could reduce painful side effects of common cancer treatment
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma…
Patients with blood cancer precursor at risk of developing cancer even after 30 years
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma…
‘Double decker’ antibody technology fights cancer
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…
Promising new therapeutic approach rebuilds and strengthens bones in multiple myeloma
An Australian-led research team has demonstrated a new therapeutic approach that can rebuild and strengthen…
ASCO 2017: CAR T-Cell Therapy Sends Multiple Myeloma Into Lasting Remission
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of…
Three drug combination extends survival for patients with multiple myeloma
For newly diagnosed patients with multiple myeloma who plan to delay autologous stem cell transplantation,…
Combination of ground-breaking treatments offer powerful new path for blood cancer therapies
Researchers have identified for the first time how a new class of epigenetic drug engages with…